BLINCYTO 35 µg
Blinatumomab
Public price
25.574,00 MAD
Active substance
Blinatumomab
Laboratory
AMANYS PHARMA (Ex Saham pharma)
What is this medicine?
BLINCYTO 35 µg contains Blinatumomab. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
Blinatumomab, Poudre lyophilisée, 35 µg, Poudre lyophilisée
Common uses
Use is linked to the active substance, the selected indication, and the pharmaceutical form.
Class
Antinéoplasique, anticorps monoclonal (anti-CD19, CD3)
Laboratory
AMANYS PHARMA (Ex Saham pharma)
Strength
35 µg
Form
Poudre lyophilisée
Presentation
Poudre lyophilisée
Therapeutic class
Antinéoplasique, anticorps monoclonal (anti-CD19, CD3)
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 25.574,00 MAD